background image

Paid Clinical Trials San Antonio

Discover 977 paid clinical trials in San Antonio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1
PHASE2

Sponsor:

Moderna

Location:

San Antonio, Austin, Victoria, Port Lavacashow 42 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Recruiting
PHASE1
PHASE2

Sponsor:

Aulos Bioscience, Inc.

Location:

San Antonio, Houston, Nashville, Salt Lake Cityshow 2 more

Code:

NCT05267626

Conditions

Advanced Solid Tumor

Metastatic Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AU-007

Aldesleukin

Avelumab

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Recruiting
PHASE3

Sponsor:

GB002, Inc.

Location:

San Antonio, Houston, Dallas, Planoshow 47 more

Code:

NCT05934526

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Seralutinib

Generic Dry Powder Inhaler

An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS

Recruiting

Sponsor:

XenoPort, Inc.

Location:

San Antonio, Gulf Breeze, Saint Louis, Nashvilleshow 8 more

Code:

NCT02560766

Conditions

RLS

Eligibility Criteria

Sex: All

Age: 13 - 17

Healthy Volunteers: Not accepted

Interventions

HORIZANT 300 mg

HORIZANT 600 mg

Placebo

First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer

Recruiting
PHASE1

Sponsor:

TORL Biotherapeutics, LLC

Location:

San Antonio, Saint Louis, Fort Wayne, Fullertonshow 2 more

Code:

NCT05156866

Conditions

Advanced Solid Tumor

Gastric Cancer

Pancreas Cancer

Gastroesophageal Junction Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TORL-2-307-ADC

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Recruiting
PHASE1
PHASE2

Sponsor:

OncoResponse, Inc.

Location:

San Antonio, Austin, Irving, Fairfax

Code:

NCT06090266

Conditions

Cancer

Tumor, Solid

Malignant Neoplasm

Metastatic Cancer

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OR502

Cemiplimab

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Kerrville, Austin, Georgetown, Katyshow 195 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

San Antonio, Boerne, Victoria, Kingwoodshow 64 more

Code:

NCT06502366

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BDA MDI HFO 160/180 μg

BDA MDI HFA 160/180 μg

Placebo MDI HFA

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

San Antonio, Sugar Land, Angleton, Houstonshow 638 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

Recruiting
PHASE2

Sponsor:

CinPhloro Pharma, LLC

Location:

San Antonio, Bellaire, Houston, Pharrshow 43 more

Code:

NCT06153420

Conditions

Irritable Bowel Syndrome With Diarrhea

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CIN-103

Placebo

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Recruiting
PHASE3

Sponsor:

Hoffmann-La Roche

Location:

San Antonio, Aurora, Omaha, Atlantashow 7 more

Code:

NCT04958265

Conditions

Atypical Hemolytic Uremic Syndrome

Eligibility Criteria

Sex: All

Age: 28 - 17

Healthy Volunteers: Not accepted

Interventions

Crovalimab

With a robust healthcare network and several renowned medical research institutions, San Antonio is a key hub for clinical research. Leading organizations such as UT Health San Antonio, Brooke Army Medical Center, and the Texas Biomedical Research Institute are at the forefront of groundbreaking studies.

These institutions are recognized for their expertise in areas like cancer, infectious diseases, trauma care, and military health, positioning San Antonio as an important city in advancing medical research and improving patient outcomes.

Why choose San Antonio for clinical trials?

Common conditions studied in San Antonio

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in San Antonio